Poging GOUD - Vrij

Duplantis soars to impossible heights

Mint Hyderabad

|

May 10, 2025

Swedish-American pole-vaulter Mondo Duplantis breaks multiple records, cementing his status as an all-time great

- Rudraneil Sengupta

In 2024, there were athletes, and then there was Mondo Duplantis. To describe that season, words are hard to come by, and Duplantis himself mutters things like "weird" and "surreal".

But if there's one word that, casting aside superlatives, captures the essence of the 25-year-old Swedish-American pole-vaulter's year—15 wins in 15 competitions, world champion, European Champion, Olympic champion, and three-time world record breaker—it's this: impossible.

Any athlete operating in the top tier would like to believe that they are chasing the impossible, that they are on a quest to turn dreams into reality.

Once in a generation, that really happens. Duplantis belongs, with consummate ease, in the same sphere as Usain Bolt, Michael Phelps, Simone Biles and Eliud Kipchoge. So far ahead of the rest that during the Paris Olympics, with the pole-vault competition done—in fact all events for the day were over—and the gold in his pocket, Duplantis, who still had a couple of jumps left, if he wished to take them, decided to go for the world record.

More than 77,000 people inside the sweltering, heaving Stade De France roared and chanted, "Mondo, Mondo, Mondo". Even his opponents, the entire pool of finalists in the men's pole vault, stood on the sidelines egging him on. He had won the Olympic gold with a 6.0m jump, so he first loosened up with a 6.10m jump to set the Olympic record. Then he raised the bar to 6.25m, jack-knifed and soared over it like only he can, accompanied by a deafening wall of sound, to break the world record for the ninth time.

Duplantis had become the first man to break the pole-vault world record in an Olympic final and the first to win back-to-back Olympic golds in the event since US's Bob Richards in 1952 and 1956.

MEER VERHALEN VAN Mint Hyderabad

Mint Hyderabad

Mint Hyderabad

Nvidia, Eli Lilly to invest $1 bn in AI lab

Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence (AI) in the pharmaceutical industry.

time to read

1 min

January 13, 2026

Mint Hyderabad

Shadowfax IPO to open next week

Logistics services provider Shadowfax is set to launch its ₹1,900-crore initial public offering (IPO) next week, targeting a valuation of ₹7,400 crore, people familiar with the matter said on Monday.

time to read

1 min

January 13, 2026

Mint Hyderabad

The US climate cop-out should galvanize others

America's withdrawal from the global battle against climate change is a signal for the rest of the world to unite for the greater good. The cause is vital, not the participation of the US

time to read

2 mins

January 13, 2026

Mint Hyderabad

Toyota pushes for fuel norm clarity

The government should soon come out with the final notification for the next phase of India’s Corporate Average Fuel Efficiency standards so that the industry can prepare accordingly, according to a senior Toyota Kirloskar Motor executive.

time to read

1 min

January 13, 2026

Mint Hyderabad

Food effect lifts Dec CPI inflation

India's retail inflation rose for the second successive month in December, data released by the statistics ministry on Monday showed, driven by a moderation in negative food inflation and an uptick in core inflation.

time to read

1 min

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Commissions trump advice in wealth management biz

surge on rising affluence, strong economic growth, higher foreign direct investments, and the growth of the startup ecosystem.

time to read

2 mins

January 13, 2026

Mint Hyderabad

The Chinese company taking on the world's memory-chip giants

As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders

time to read

4 mins

January 13, 2026

Mint Hyderabad

HC lifts ban on Zydus cancer biosimilar till patent expiry

In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.

time to read

2 mins

January 13, 2026

Mint Hyderabad

Fix GST on capital goods to revive private investment

India faces a paradox today.

time to read

3 mins

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Feeling tired? It could be too many messages

The cumulative stress of constant notifications is leaving many emotionally burnt out. Tackling it requires small, sustainable changes

time to read

4 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size